Navigation Links
Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
Date:8/23/2011

Genomatix has recently won the "Most Creative Visualization" award in the "commercial" category of Illumina's Data Excellence (iDEA) Challenge 2011, an achievement we are extremely proud of. iDEA is Illumina's program designed to challenge the scientific community to develop new and creative visualization and data analysis techniques.

"The iDEA challenge really sparked our interest from the very first moment we heard about it. Genomatix is a scientific company at heart, and we felt that getting our hands on a high quality, widely diverse dataset like the one Illumina provided for the Challenge would be an ideal test for our scientific approach to data analysis... which is to combine multiple lines of evidence to get from sequencing data to biological knowledge" says Dr. Jochen Supper, who presented Genomatix' submission at the San Diego iDEA meeting.

Dr. Martin Seifert, CEO of Genomatix, adds: "The Challenge was judged by a panel of renowned experts from the scientific community, and this is a great endorsement of the work we've done to date, as well as a significant motivation to push even harder in the future. Genomatix has always focused on providing intuitive interfaces and easy-to-understand visualizations. The combination of our scientifically validated algorithms and wealth of annotation data allows us to offer a comprehensive platform solution for Next Generation Sequencing data analysis. With the iDEA data being generated from cancer cell lines it also underlines the increasing relevance of our technologies for medical applications."


'/>"/>

Contact: Dr. Korbinian Grote
grote@genomatix.de
Genomatix Software GmbH
Source:Eurekalert  

Page: 1

Related biology news :

1. Genomatix joins Illumina-Connect program
2. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
3. CRG buys Genomatix Next Generation Sequencing analysis solution
4. Genomatix gets patent for comparative genomics method
5. MCTP bought Genomatix NextGen Sequencing analysis stations
6. University of Michigan installs second Genomatix Genome Analyzer
7. Genomatix gives a hand in the analysis of Wayne States sequencing projects
8. Eurofins MWG Operon and Genomatix launch strategic alliance
9. Eurofins MWG Operon and Genomatix developed most complete human exome array
10. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
11. Dr. Harmit Malik receives Vilcek Prize for creative promise in biomedical science
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: